QC
BIO icon

Quantedge Capital’s Bio-Rad Laboratories Class A BIO Stock Holding History

Quantedge Capital’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-6,940
Closed -$1.93M – 53
2026
Q1 		$1.93M Sell
6,940
-7,200
-51% -$2.07M 1.06% 22
2025
Q4 		$4.28M Sell
14,140
-11,660
-45% -$3.64M 2.04% 14
2025
Q3 		$7.23M Buy
+25,800
New +$7.02M 3.96% 6

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Quantedge Capital's BIO Position: Q2 2026 in Review

Quantedge Capital sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2026, closing a stake of 6,940 shares — an estimated $1.93M sold.

Quantedge Capital first reported a position in BIO in Q3 2025 and held it in 3 quarters. The position peaked at $7.23M in Q3 2025. 399 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Quantedge Capital reported no remaining Bio-Rad Laboratories Class A position as of Q2 2026 after selling out during the quarter.
  • Quantedge Capital sold 6,940 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $1.93M.
  • Quantedge Capital first reported a position in Bio-Rad Laboratories Class A in Q3 2025 and held it in 3 quarters.
  • Quantedge Capital's Bio-Rad Laboratories Class A position peaked at $7.23M in Q3 2025.
  • 399 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Quantedge Capital's 13F filing for Q2 2026, filed 6 Aug 2026.